Galectin Therapeutics Inc. Share Price
NASDAQ: GALT | Micro CapGalectin Therapeutics Inc. Stock Performance
Galectin Therapeutics Inc. Share Price Today
As of 30 October 2026, Galectin Therapeutics Inc.'s share price is $3.53. The stock opened at $3.63, compared to its previous close of $3.55. During today's trading session, Galectin Therapeutics Inc.'s share price traded between $3.48 and $3.63, with an average price of $3.55. Over the past 52 weeks, the stock has recorded a high of $7.13 and a low of $2.02. In terms of performance, Galectin Therapeutics Inc.'s share price has risen by 56.19% over the last six months and is down 39.14% on a year-on-year basis.
Galectin Therapeutics Inc. Share Price Chart
Galectin Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Galectin Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Galectin Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.94 | $3.52 | -9.74% |
Sep 2026 | $4.03 | $3.90 | -5.91% |
Aug 2026 | $3.05 | $4.14 | +39.80% |
Jul 2026 | $4.61 | $2.96 | -35.96% |
Jun 2026 | $2.52 | $4.63 | +83.73% |
May 2026 | $2.25 | $2.52 | +11.50% |
Apr 2026 | $2.84 | $2.26 | -19.00% |
Mar 2026 | $3.06 | $2.79 | -6.22% |
Feb 2026 | $2.90 | $2.98 | +5.12% |
Jan 2026 | $4.22 | $2.83 | -31.81% |
Dec 2025 | $5.71 | $4.15 | -27.19% |
Nov 2025 | $5.71 | $5.70 | -1.72% |